CARCINOGENESIS: NITROSAMINE FORMATION AND INHIBITION
致癌:亚硝胺的形成和抑制
基本信息
- 批准号:3482074
- 负责人:
- 金额:$ 11.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1980
- 资助国家:美国
- 起止时间:1980-02-01 至 1991-11-30
- 项目状态:已结题
- 来源:
- 关键词:alkaloids antibacterial agents antihistamines carcinogen testing carcinogenesis inhibitor chemical carcinogen chemical carcinogenesis chemical reaction chemical structure function drug adverse effect drug carcinogenesis environment related neoplasm /cancer environmental toxicology food contamination gas chromatography high performance liquid chromatography indoles mass spectrometry mutagen testing nitrogen compounds nitrosamines nitroso compounds nuclear magnetic resonance spectroscopy nutrition related tag occupational hazard polymers pyrroles quaternary ammonium compound sedative /hypnotic skin stoichiometry tertiary amine toxicant screening toxin metabolism
项目摘要
The proposed research as a high probability of identifying
important chemical features which both predispose and serve to
block or inhibit the rapid formation of carcinogenic nitrosamines
from certain nitrogen compounds both in vivo and in the
environment. There are many gaps in our knowledge of the
molecular and other chemical factors which lead to rapid or
significant nitrosamine formation. It is not know, for example,
how nitrosamines are formed in cosmetics, shampoos, other
toiletry items, metalworking fluids, and tobacco. Endogenous
formation of many N-nitroso compounds may go undetected
because of their rapid and possible injurious metabolism. We
believe that a fundamental understanding of the chemistry of the
nitrosation process, particularly as it relates to ternary nitrogen
compounds, can lead to methods for eliminating or decreasing
exposure to nitrosamines and thereby prevent human cancer.
The rapid formation of nitrosamines from ternary nitrogen
compounds including tertiary amines containing an electron rich
aromatic ring, tertiary amidines, and gem diamines, will be
examined with respect to the necessary structural features and
the variables of endogenous nitrosation, nitrite level, pH, and -
SCN concentration. Several complex drugs and food constituents
including reserpine, hexetidine, methaphenaline, amidinocillin and
medibazine will be screened for mutagenicity. Pyrroles and
polymers containing pyrroles will be examined for their ability to
block nitrosamine formation. Ester mediated nitrosation, a
reaction discovered through this research and possibly responsible
for inadvertent nitrosamine formation in commercial samples,
will be further elucidated.
建议的研究作为一个高概率的识别
重要的化学特征,既易患,又有助于
阻断或抑制致癌亚硝胺的快速形成
从某些氮化合物在体内和
环境 在我们的知识中有许多空白,
分子和其他化学因素,导致快速或
明显的亚硝胺形成。 例如,我们不知道,
亚硝胺是如何在化妆品、洗发水和其他
化妆品、金属加工液和烟草。 内源
许多N-亚硝基化合物的形成可能未被发现
因为它们的新陈代谢太快而且可能有害。 我们
我相信,对化学的基本理解,
亚硝化方法,特别是涉及三元氮的亚硝化方法
化合物,可以导致消除或减少
暴露于亚硝胺,从而预防人类癌症。
由三元氮快速生成亚硝胺
含有富电子的叔胺等化合物
芳环,叔脒,和宝石二胺,将是
检查了必要的结构特征,
内源性亚硝化、亚硝酸盐水平、pH值和-
SCN浓度。 几种复杂的药物和食物成分
包括利血平、海克替丁、美沙非那林、脒基青霉素和
将筛选Medibazine的致突变性。 吡咯和
将检查含有吡咯的聚合物的能力,
阻断亚硝胺的形成。 酯介导的亚硝化反应,
通过这项研究发现的反应,
对于商业样品中意外的亚硝胺形成,
将进一步阐明。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard N Loeppky其他文献
Richard N Loeppky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard N Loeppky', 18)}}的其他基金
ENDOGENOUS NITROSATION CHEMISTRY IN CARCINOGENESIS
致癌过程中的内源亚硝化化学
- 批准号:
6633656 - 财政年份:2000
- 资助金额:
$ 11.1万 - 项目类别:
ENDOGENOUS NITROSATION CHEMISTRY IN CARCINOGENESIS
致癌过程中的内源亚硝化化学
- 批准号:
6710716 - 财政年份:2000
- 资助金额:
$ 11.1万 - 项目类别:
ENDOGENOUS NITROSATION CHEMISTRY IN CARCINOGENESIS
致癌过程中的内源亚硝化化学
- 批准号:
6514417 - 财政年份:2000
- 资助金额:
$ 11.1万 - 项目类别:
ENDOGENOUS NITROSATION CHEMISTRY IN CARCINOGENESIS
致癌过程中的内源亚硝化化学
- 批准号:
6086491 - 财政年份:2000
- 资助金额:
$ 11.1万 - 项目类别:
ENDOGENOUS NITROSATION CHEMISTRY IN CARCINOGENESIS
致癌过程中的内源亚硝化化学
- 批准号:
6377782 - 财政年份:2000
- 资助金额:
$ 11.1万 - 项目类别:
MECHANISM OF N-NITROSODIETHANOLAMINE CARCINOGENSIS
N-亚硝基二乙醇胺致癌机制
- 批准号:
2292428 - 财政年份:1994
- 资助金额:
$ 11.1万 - 项目类别:
相似海外基金
Development of rapid detection method for drug-resistant bacteria in pulmonary MAC disease and search for new antibacterial agents
肺部MAC疾病耐药菌快速检测方法的建立及新型抗菌药物的寻找
- 批准号:
23K07930 - 财政年份:2023
- 资助金额:
$ 11.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel antibacterial agents using crystal structure-based drug screening
利用基于晶体结构的药物筛选开发新型抗菌剂
- 批准号:
23K07918 - 财政年份:2023
- 资助金额:
$ 11.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ATP Synthase as an emerging target for the pre-clinical development of broad-spectrum antibacterial agents against drug-resistant bacterial infections
ATP 合酶作为针对耐药细菌感染的广谱抗菌药物临床前开发的新兴靶标
- 批准号:
472342 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Operating Grants
Clinical application of a rapid assay for antibacterial susceptibility test of beta-lactams and carbapenems antibacterial agents using MALDI-TOF MS
MALDI-TOF MS快速测定β-内酰胺类和碳青霉烯类抗菌药物药敏试验的临床应用
- 批准号:
22K07406 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tailored and uniform fibre-like micelles as antibacterial agents.
定制且均匀的纤维状胶束作为抗菌剂。
- 批准号:
569719-2022 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Postgraduate Scholarships - Doctoral
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2022
- 资助金额:
$ 11.1万 - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2021
- 资助金额:
$ 11.1万 - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2021
- 资助金额:
$ 11.1万 - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2020
- 资助金额:
$ 11.1万 - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents.
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体。
- 批准号:
531450-2018 - 财政年份:2020
- 资助金额:
$ 11.1万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




